Ann: Nicotinamide Penetration Study, page-103

gees icy, have you read the Ann about the appointment of Parfix as our manufacturing partner.

here's a bit of it

"The Board is pleased to be partnering with Parafix and will be looking to draw on their significant expertise in materials, PRODUCTION ECONOMICS and quality assurance to assist the Company’s push towards a targeted commercial launch of the Kneeguard product in Q2 2020 (subject to regulatory approvals)."

I highlighted a section in capitals. I wonder if we would appoint Parafix if the production costs were too high. grabbing at straws to say this deal could fall over at this early stage !!!